US Patent 9169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
Patent 9169246 was granted and assigned to Sanofi on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+78 characters)
Article
Patent abstract
The invention relates to compounds corresponding to formula (I)
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof US Patent 9169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
Infobox
Patent Number
09169246
Patent Number
9169246
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09169246
Date of patent
October 27, 2015
Patent application number
13245468
Date Filed
September 26, 2011
Patent primary examiner
Find more entities like US Patent 9169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.